Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
17,553,121
-
Total 13F shares
-
10,952,092
-
Share change
-
-685,283
-
Total reported value
-
$129,272,317
-
Put/Call ratio
-
12%
-
Price per share
-
$11.80
-
Number of holders
-
97
-
Value change
-
-$16,307,156
-
Number of buys
-
45
-
Number of sells
-
46
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q4 2024
As of 31 Dec 2024,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,952,092 shares.
The largest 10 holders included
Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, Octagon Capital Advisors LP, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, Altium Capital Management LLC, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.